Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
University Hospitals Brain Health & Memory Center is now treating patients with KISUNLAâ„¢ (donanemab), a Food and Drug ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...
The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for ... assistant professor of sleep medicine and memory and cognitive disorders, and program director ...
Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...
Red No. 3, chemically known as erythrosine, was first introduced into foods in 1907. Companies subsequently added it to ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...
The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback